Lijuan Zhang

Lijuan Zhang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2022 in World Journal of Clinical Cases
Verified
Journal Article
Open access
QZQiao-Ling Zhong
Qiao-Ling Zhong
HZHui-Ting Zhang
Hui-Ting Zhang
QLQing-Hua Luo
Qing-Hua Luo
HTHai-Lin Tang
Hai-Lin Tang
LZLijuan Zhang
Lijuan Zhang
Complex decongestive therapy (CDT) is currently recommended as the standard treatment for lymphedema. CDT is a four-step detumescence therapy that can effectively treat upper limb lymphedema after breast cancer surgery, and is considered non-invasive, painless and without side effects. To determine the effectiveness of a six-step CDT involving a foam granule bandage for the treatment of upper extremity lymphedema pressure after breast cancer surgical intervention. The study included 100 patients with upper extremity lymphedema after breast cancer surgery. The surgical methods were mastectomy plus axillary lymph node dissection and breast preservation plus sentinel lymph node biopsy. The study population was further divided into the experimental group and control group with 50 cases in each group. The control group was given conventional CDT (four-step method), which included skin care, freehand lymphatic drainage, foam granule pressurized bandage, and functional exercise. In the experimental group, a six-step CDT method was applied that involved a foam particle bandage combined with air wave pressure therapy in addition to the four steps of conventional CDT. Patients in both groups were given one course of treatment daily (20 times), and the changes in body moisture and subjective symptoms were measured before and after treatment, preoperatively and 20 times after treatment. No statistically significant differences in 50-Hz bioelectrical impedance and extracellular moisture ratio were observed between the two groups before treatment, suggesting comparability of the baseline data. After treatment, the 50-Hz bioelectrical impedance of the experimental group was significantly higher than that in the control group, and the extracellular moisture ratio was significantly lower than that in the control group. A comparison of the differences between the two groups before and after treatment indicated that the treatment effect in the experimental group was better than that in the control group. After 20 treatments, according to subjective evaluations, the tightness and swelling of the limbs in the experimental group were significantly reduced as compared with those in the control group. The six-step CDT method can effectively reduce lymphedema, promote lymphatic circulation, and alleviate the subjective symptoms of patients, and thereby improve the quality of life and treatment compliance among patients.

1 January 2023 in European Journal of Cancer Care
Verified
Journal Article
Open access
PDF file
FPFulin Pu
Fulin Pu
LZLijuan Zhang
Lijuan Zhang
YZYiheng Zhang
Yiheng Zhang
SSShihao Sun
Shihao Sun
NLNa Li
Na Li
MZMeifen Zhang
Meifen Zhang
Background . Adherence to complete decongestion therapy (CDT) is of utmost importance for patients with breast cancer‐related lymphedema (BCRL). However, past studies have demonstrated that adherence to CDT in BCRL patients is less than satisfactory. Our study aimed to describe the level of adherence to CDT among BCRL patients and utilize the Health Belief Model to analyse the key factors that influence adherence. Methods . We employed a convenient sampling method to select 158 patients with BCRL who were in the maintenance stage of CDT in a grade A tertiary tumour hospital in Guangzhou. A questionnaire survey was used to investigate patients’ adherence to CDT, as well as their sociodemographic characteristics, medical history characteristics, disease knowledge, and health beliefs. Results . The CDT adherence score of BCRL patients was 96.46 ± 18.46 points, with an average score of 2.61 ± 0.50 points per item. The adherence rate was 65.18 ± 12.47%, indicating a moderate level of adherence. Factors that significantly influenced CDT adherence in BCRL patients included age under 45 years, having 0 or 1 child, experiencing 9 lymphedema symptoms, and having low levels of disease knowledge and health beliefs ( p < 0.05). Conclusions . The level of adherence to CDT in BCRL patients is moderate and requires improvement. To enhance adherence to CDT, medical professionals should focus on patients who are younger, have fewer children, exhibit fewer symptoms of lymphedema, possess limited disease knowledge, and have weak health beliefs.

10 April 2026 in JMIR Cancer
Verified
Journal Article
Open access
YDYun Ding
Yun Ding
HZHuiting Zhang
Huiting Zhang
QZQiaoling Zhong
Qiaoling Zhong
LZLijuan Zhang
Lijuan Zhang
HQHuiying Qin
Huiying Qin
Background: Fear of cancer recurrence (FCR) is a common psychological disorder among patients with cancer. In patients newly diagnosed with breast cancer, fear and concern about recurrence often influence treatment decision-making. However, the prevalence of FCR before treatment and its key risk factors—such as age, sleep quality, economic status, self-disclosure, and social support—remain unclear. Objective: This study aims to describe the prevalence and severity of FCR before treatment in patients newly diagnosed with breast cancer and analyze its predictive factors, thereby providing a scientific basis for interventions to reduce such fear. Methods: A cross-sectional study was conducted among patients newly diagnosed with breast cancer prior to treatment at a specialized oncology hospital in Guangdong Province, China, between February 2023 and July 2023. Sociodemographic data were collected, including age, gender, ethnicity, religious belief, education level, and marital status. Clinical data included pathological stage, tumor type, and family history of cancer. The Distress Disclosure Index, the Chinese version of the Medical Social Support Scale, and the short form of the Fear of Progression Questionnaire were used. Univariate analyses and bivariate correlations were conducted to explore relationships between variables. Multiple regression analysis was performed to identify predictors of FCR. Results: A total of 350 patients newly diagnosed with breast cancer were enrolled. Among the participants, 48.3% (n=169) experienced FCR before initiating treatment. The mean total score for FCR was 33.44 (SD 8.00). Age, sleep quality, financial burden, monthly household income per capita, family relationships, self-disclosure, and social support accounted for 33.5% ( R ²) of the variance in FCR. Conclusions: FCR prior to treatment is common and relatively severe among patients newly diagnosed with breast cancer. Health care professionals should implement targeted interventions to promote self-disclosure and strengthen social support networks to alleviate FCR, facilitate informed treatment decision-making, and improve patients’ psychological readiness for treatment. The findings of this study underscore the urgent need for early identification and management of FCR in patients newly diagnosed with breast cancer. High levels of pretreatment FCR may impair patients’ psychological well-being and influence treatment decision-making, potentially leading to suboptimal treatment choices. Health care professionals should implement targeted interventions that promote self-disclosure and strengthen social support networks to alleviate FCR. These measures can enhance patients’ psychological readiness for treatment, facilitate informed decision-making, and ultimately improve clinical outcomes.

1 January 2026 in SAGE Open Nursing
Verified
Journal Article
Open access
QZQiaoling Zhong
Qiaoling Zhong
YGYuezhou Guo
Yuezhou Guo
FLFeng Liu
Feng Liu
QLQinghua Luo
Qinghua Luo
HZHuizhen Zhang
Huizhen Zhang
LZLijuan Zhang
Lijuan Zhang
Introduction: This study examined alexithymia, illness-related stigma, and self-esteem among patients with lymphedema to provide evidence for improving self-esteem, enhancing emotional expression, and reducing stigma. Objectives: To describe levels of alexithymia, illness-related stigma, and self-esteem in patients with lymphedema; examine demographic differences; and test prespecified associations among these variables. Methods: This was a cross-sectional, questionnaire-based study. A convenience sample of 195 patients with lymphedema receiving treatment at a tertiary oncology hospital in southern China completed questionnaires between October 2020 and February 2021. Instruments included the Toronto Alexithymia Scale, Social Impact Scale, and Rosenberg Self-Esteem Scale. Descriptive statistics summarized patient characteristics and scores. Group differences were tested with t-tests, analysis of variance, and rank-sum tests. Results: The mean alexithymia score was 56.53 ± 8.43, with externally oriented thinking highest and difficulty describing emotions lowest. Alexithymia differed by education, marital status, residence, income, and activity after onset ( p < .05). The mean stigma score was 60.36 ± 11.08, highest for social exclusion and lowest for internalized shame, differing by income, personality, and family relationships ( p < .05). The mean self-esteem score was 27.84 ± 4.07, differing by education, employment, residence, income, personality, activity, and family relationships ( p < .05). Alexithymia correlated positively with stigma (r = .51, p < .01) and negatively with self-esteem (r = −.65, p < .01). Stigma correlated negatively with self-esteem (r = –.60, p < .01). Conclusion: Economic discrimination was the strongest correlate of stigma, and income and family relationships were key associated factors. Interventions targeting emotional expression and self-esteem may be relevant for psychosocial support in this population.